Salvage Therapy with Intraoperative Cesium-131 for Recurrent Ovarian Cancer
Abstract
Recurrent ovarian cancer is considered incurable and the current standard of treatment (surgery and chemotherapy) is palliative. For isolated, localized recurrent tumor, brachytherapy with Cesium-131 is a promising treatment because of its localized radiation yet limited exposure to healthy tissue. Compared to its predecessors, Cs-131 has a very short half-life, allowing for highly localized radiation that decreases toxicity of treatment and convenience for the patient. Our case shows a patient diagnosed with recurrent ovarian cancer metastatic to the right paraaortic odes. The first successful application of Cs-131 brachytherapy was performed with 100% local control without added toxicity. This shows a favorable addition to the current standard of care for highly localized ovarian cancers.
Keywords
Full Text:
PDFReferences
Cho KR, Shih LM. Ovarian Cancer. Annu Rev Pathol. 2009, 4:287-313
Storey DJ, Rush R, Stewart M, Rye T, Al-Nafussi A, Williams AR, Smyth JF, Gabra H. Endometroid Epithelial Ovarian Cancer. Cancer. 2008, 112(10):2211-2220
Mann WJ, Chalas E, Valea FA. Cancer of the ovary, fallopian tube, and peritoneum: Staging and initial surgical management. Waltham, MA: UpToDate; 2015 November. Available from: http://www.uptodate.com/contents/cancer-of-the-ovary-fallopian-tube-and-peritoneum-staging-and-initial-surgical-management?source=see_link#H403752
Mahantshetty U, Jamema S, Engineer R, Deshpande D, Sarin R, Fogliata A, Nicolini G, Clivio A, Vanetti E, Shrivastava S, Cozzi L. Whole abdomen radiation therapy in ovarian cancers: a comparison between fixed beam and volumetric arc based intensity modulation. Radiation Oncology. 2010, 5:106
Dembo AJ. Epithelial Ovarian Cancer: The Role of Radiopathy. Radiation Oncology. 1992, 22(5): 835-845
Skirnisdottir I, Nordqvist S, Sorbe B. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past? Oncol Rep. 2005, 14(2):521-529
Kehwar TS. Use of Cesium-131 radioactive seeds in prostate permanent implants. J Med Phys. 2009, 34(4):191-193
Parashar B, Wernicke AG, Pavese A, Singh P, Trichter S, Sabbas A, Kutler DI, Kuhel W, Port JL, Lee PC, Nori D, Chao KSC. Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. Brachytherapy. 2011, 10(6):508-513
Henschke UK, Lawrence DC. Cesium-131 Seeds for Permanent Implants. Radiology. 1965 December; 86(6):1117-1119
Wooten CE, Randall M, Edwards J, Aryal P, Luo W, Feddock J. Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies. Gynecol Oncol. 2014, 133(2):268-273
Refbacks
- There are currently no refbacks.
